12
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Chiral Separation of Acebutolol by Derivatization and High-Performance Liquid Chromatography

, &
Pages 3329-3345 | Received 01 Apr 1995, Accepted 18 Apr 1995, Published online: 23 Sep 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (4)

Mohamed Abdelfattah El Dawya, Mokhtar Mohamed Mabrouk & Riad Ahmed El Barbary. (2006) Spectrofluorimetric Determination of Drugs Containing Active Methylene Group Using N1-Methyl Nicotinamide Chloride as a Fluorigenic Agent. Chemical and Pharmaceutical Bulletin 54:7, pages 1026-1029.
Crossref
M. Péter, Á. Gyéresi & F. Fülöp. (2001) Liquid chromatographic enantioseparation of β-blocking agents with (1R,2R)-1,3-diacetoxy-1-(4-nitrophenyl)-2-propyl isothiocyanate as chiral derivatizing agent. Journal of Chromatography A 910:2, pages 247-253.
Crossref
Jacek Bojarski & Hassan Y. Aboul-Enein. (1999) Recent chromatographic and electrophoretic enantioseparations of cardiovascular drugs. Biomedical Chromatography 13:3, pages 197-208.
Crossref
Joanna Szymura-Oleksiak, Maria Walczak, Jacek Bojarski & Hassan Y. Aboul-Enein. (1999) Enantioselective high performance liquid chromatographic assay of acebutolol and its active metabolite diacetolol in human serum. Chirality 11:4, pages 267-271.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.